Cavosonstat
- Generic Name
- Cavosonstat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H10ClNO3
- CAS Number
- 1371587-51-7
- Unique Ingredient Identifier
- O2Z8Q22ZE4
- Background
Cavosonstat is under investigation in clinical trial NCT02589236 (Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation).
- Associated Conditions
- -
- Associated Therapies
- -
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
Phase 2
Active, not recruiting
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2019-10-17
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 395
- Registration Number
- NCT04129931
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸University of California San Diego: Airway Research & Clinical Trials Center, San Diego, California, United States
🇺🇸University of California San Francisco, San Francisco, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath